InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Planopenny Free
02/09/21 7:55 AM
profile icon
CogDiss 1188X Free
02/08/21 11:54 PM
profile icon
georgie18 PremiumMember
02/06/21 3:56 AM
profile icon
georgie18 PremiumMember
01/28/21 5:38 AM
profile icon
Fress Free
01/21/21 8:23 AM
profile icon
Planopenny Free
01/19/21 8:16 AM
profile icon
Fress Free
01/19/21 7:47 AM
profile icon
Fress Free
01/14/21 12:52 PM
profile icon
Planopenny Free
01/14/21 12:41 PM
profile icon
Fress Free
01/08/21 9:38 AM
profile icon
Fress Free
01/07/21 5:54 PM
profile icon
Planopenny Free
01/06/21 1:52 PM
profile icon
Fress Free
01/06/21 11:21 AM
profile icon
georgie18 PremiumMember
12/31/20 5:15 PM
profile icon
Fress Free
12/31/20 5:01 PM
profile icon
Fress Free
12/31/20 2:06 PM
profile icon
georgie18 PremiumMember
12/30/20 10:19 AM
profile icon
Planopenny Free
12/29/20 10:11 PM
profile icon
georgie18 PremiumMember
12/29/20 7:43 PM
profile icon
Planopenny Free
12/18/20 8:05 PM
profile icon
Porterhouse10 Free
12/18/20 7:47 PM
profile icon
Porterhouse10 Free
12/18/20 7:45 PM
profile icon
Planopenny Free
12/11/20 9:57 AM
profile icon
Planopenny Free
11/11/20 8:41 AM
profile icon
Planopenny Free
11/11/20 8:39 AM
profile icon
Planopenny Free
10/14/20 10:17 AM
profile icon
KOmani Free
10/12/20 4:02 PM
profile icon
Planopenny Free
10/12/20 3:53 PM
profile icon
Planopenny Free
10/12/20 2:03 PM
profile icon
georgie18 PremiumMember
10/07/20 3:20 PM
profile icon
georgie18 PremiumMember
10/07/20 3:02 PM
profile icon
georgie18 PremiumMember
10/05/20 3:17 PM
profile icon
Planopenny Free
10/05/20 1:29 PM
profile icon
georgie18 PremiumMember
09/18/20 11:14 AM
profile icon
georgie18 PremiumMember
09/02/20 9:32 AM
profile icon
georgie18 PremiumMember
09/01/20 10:14 AM
profile icon
georgie18 PremiumMember
09/01/20 9:08 AM
profile icon
georgie18 PremiumMember
08/20/20 8:49 AM
profile icon
georgie18 PremiumMember
08/11/20 6:54 AM
profile icon
georgie18 PremiumMember
08/04/20 10:28 AM

Surface Oncology Inc (SURF) RSS Feed

Followers
14
Posters
27
Posts (Today)
0
Posts (Total)
116
Created
12/28/18
Type
Free
Moderators
Cathie Wood from ARKG owns 10% and keeps adding shares. of the SURF float Eli Lily holds 8.5% through LLV ventures fund. institutions own 67% of the 40 million shares outstanding

Cash runway through 2023 ($102.5M in cash as of Sept 30th; received $85Million from GSK GlaxoSmithKline in December.


Two strategic partnerships (Novartis & GSK GlaxoSmithKline) validate strong IO drug discovery capabilities.

GSK GlaxoSmithKline Partnership SRF813
cumulative milestones up to $730 million
• Tiered royalties on annual net sales
(high single-digit to mid-teens %


Novartis Partnership: NZV930

• Upfront payment of $70M, total
cumulative milestones up to $525 million
• Tiered royalties on annual net sales
(high single-digit to mid-teens %)


The company received a takeover approach from GlaxoSmithKline (GSK)
and has hired an investment bank, StreetInsider reports.
Surface Oncology wants bankers to look for any other possible M&A interest beyond GSK, StreetInsider says.

https://www.streetinsider.com/Hot+M+and+A/Surface+Oncology+%28SURF%29+Explores+Potential+Sale+After+GSK+Takeover+Approach+-+Source/17458243.html

In the "Lightning Round" segment of Mad Money Friday night, Jim Cramer was bullish on Surface Oncology (SURF) , an immuno-onocolgy company developing next-generation antibody therapies.
https://realmoney.thestreet.com/investing/surface-oncology-is-set-for-further-gains-how-to-buy-it-15542979


Cathie Wood ARKG #1 wall street stock picker bought over a million SURF shares in one day a few weeks back she has doubled her position to over 4 million shares in the stock recently Cathie knows something!

Surface Oncology Announces FDA Fast Track Designation Granted by U.S. Food and Drug Administration for SRF388 to Treat Liver Cancer.
https://investors.surfaceoncology.com/news-releases/news-release-details/surface-oncology-announces-fda-fast-track-designation-granted-us


Detailed clinical update for both SRF617 & SRF388 to be presented in the first half of 2021.

SRF388 is the ONLY anti IL-27 targeted agent in late Pre clinical development. Shows antimetastatic tumour activity and increased the production of key inflammatory cytokines.

SRF388 is a blockbuster in the making, the Il-27 targeting antibody. There is compelling evidence clinically to understand IL-27s role in tumour types. This is the next one that will get huge partnership deal!! Can’t wait for phase 1 data.


Surf recap: Partnership with Novartis worth
$525M
(For SRF373)Partnership with GSK GlaxoSmithKline worth
$730M
(For SRF813)

Total = 1.15B just for licence worldwide rights.

SURF has 4 other VERY promising targets. SRF617,SRF388, SRF114,SRF231 More partnership deals to come.
undervalued and the chart is bullish 1 year is amazing building & looking for continuation to the upside.


https://stockcharts.com/h-sc/ui?s=SURF

Outstanding team of experienced company builders & oncology drug developers.



Feb 2021 Biz presentation:
https://investors.surfaceoncology.com/static-files/9a6d888d-dae2-419d-a0fc-c96058f9aa7c

Surf Website:
https://www.surfaceoncology.com/

Surf Pipeline & Programs:
https://www.surfaceoncology.com/pipeline-programs/
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
SURF Latest News
  • No Recent News Available for this company!
New Post